Leveraging Network Experimentation and Surrogate Index to Estimate Treatment Effects

Leveraging Network Experimentation and Surrogate Index to Estimate Treatment Effects

Introduction:
Network experimentation at scale has become increasingly important in various fields, including social media platforms and educational settings. The ability to conduct experiments on a large scale allows researchers and practitioners to better understand the effects of interventions and make informed decisions. However, conducting network experiments at scale presents unique challenges, such as the need to randomize units or clusters, the selection of suitable surrogates, and the estimation of treatment effects. In this article, we will explore the concepts of network experimentation, surrogate indices, and their application in estimating treatment effects.

Network Experimentation at Scale:
In network experimentation at scale, randomization plays a crucial role in ensuring unbiased treatment assignment. Figure 1 shows a visualization of the network experiment randomization process. Cluster-randomization is often used, where clusters are sampled proportional to their size. This approach helps to reduce test-control interference and provides more accurate estimates of treatment effects.

Surrogate Indices and Surrogacy Assumption:
Surrogate indices are short-term proxy variables used to estimate the effects of interventions on long-term outcomes. The surrogacy assumption states that the long-term outcome is independent of the treatment conditional on the surrogate index. This assumption allows researchers to estimate treatment effects without directly observing the long-term outcomes, which are often observed with a delay.

Validating Surrogacy Assumption:
Validating the surrogacy assumption is crucial to ensure the accuracy of treatment effect estimates. One approach is to test whether a surrogate index constructed based on early indicators tracks experimental outcomes well over time. If the surrogate index accurately predicts the long-term outcome, it provides evidence for the validity of the surrogacy assumption.

Estimating Treatment Effects:
Estimating treatment effects using surrogate indices involves several steps. First, the unconfoundedness assumption is made, which states that the treatment assignment is independent of potential outcomes given pre-treatment variables. Second, the comparability assumption is made, which assumes that the distribution of potential outcomes is the same in the experimental and observational samples. Finally, the surrogate index is used to estimate the average treatment effect.

Bias and Bounds:
When the surrogacy assumption is violated, bias can arise in the estimation of treatment effects. The degree of bias depends on the extent to which the intermediate outcomes span the causal pathways from the treatment to the primary outcome. Bounds on the degree of bias can be obtained by considering the explanatory power of the surrogates in explaining the primary outcome.

Validation and Variable Selection:
Validating the surrogacy assumption and selecting suitable surrogates are crucial steps in estimating treatment effects. Surrogates should be strongly linked to the primary outcome or the treatment to ensure accurate estimation. Variable selection procedures, such as doubly robust methods, can help in selecting effective surrogates.

Actionable Advice:

1. Conduct thorough validation of surrogate indices: Validate the surrogacy assumption by testing whether the surrogate index accurately predicts the long-term outcome over time. This validation helps ensure the accuracy of treatment effect estimates.

2. Select suitable surrogates: Choose intermediate outcomes that are strongly linked to the primary outcome or the treatment. Consider the explanatory power of the surrogates in explaining the primary outcome to select effective surrogates.

3. Use variable selection procedures: Implement variable selection procedures, such as doubly robust methods, to select the most effective surrogates. These methods take into account both the link between surrogates and the primary outcome and the explanatory power of the treatment.

Conclusion:
Network experimentation at scale provides valuable insights into the effects of interventions. Surrogate indices offer a useful approach to estimate treatment effects when long-term outcomes are not directly observed. By validating the surrogacy assumption and selecting suitable surrogates, researchers can obtain accurate estimates of treatment effects. Implementing these practices can enhance the reliability and effectiveness of network experimentation at scale.